SILVER SPRING, Md., Aug. 04, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that Chardan Capital Markets LLC, a privately held full service global investment bank specializing in micro, small and mid-cap companies, issued an Industry Update featuring PharmaCyte Biotech. The report can be viewed at www.PharmaCyte.com/reports.

BOSTON - Representatives from the company seeking to open medical marijuana dispensaries in downtown Boston and Greenfield are slated to appear before a zoning board on Tuesday.

Boston's Zoning Board of Appeals is tasked with determining whether Patriot Care Corp. should be granted a conditional use license to open a dispensary at 21 Milk St.

Patriot Care also wants to open a dispensary in Lowell, at 70 Industrial Ave. East. In Greenfield, the dispensary would be located at 7 Legion Ave.

Back on March 27, 2014, I recommended that Money Morning Members pick up what I felt was the very best play in the burgeoning cannabis biotech industry.

Today, the shares have done even better than I imagined, which is why I wanted to touch base with you again.

Right now, we're going to see how it's performed, but, even better, how to maximize the "free trade" it's about to give us.

And if you missed this stock last year – no worries. We'll start you now as it continues its run – a run that took off while "popular" medical marijuana stocks cratered.

Here's how we'll do it…

SAN DIEGO, Aug.

Chronic marijuana use by teenage boys does not appear to be linked to later physical or mental health issues such as depression, psychotic symptoms or asthma, according to a study published by the American Psychological Association.

Researchers from the University of Pittsburgh Medical Center and Rutgers University tracked 408 males from adolescence into their mid-30s for the study, which was published in Psychology of Addictive Behaviors.

For those hoping that Big Pharma could still be blocked from the medical cannabis scene there is bad news: the deal is done. Look for the first naturally-derived, Big Pharma-produced cannabis product to be on the market by the first half of 2016, perhaps even sooner.

Roughly one year after New York State Governor Andrew Cuomo passed the Compassionate Care Act—which will allow doctors to recommend and prescribe medicinal marijuana for certain illnesses starting in 2016—New York State has finally granted its first medical marijuana licenses. Last Friday, a total of five organizations were selected to produce and distribute medical marijuana across the state. The companies that were selected include Bloomsfield Industries Inc., Columbia Care NY LLC, Empire State Health Solutions, Etain LLC, and PharmaCann LLC. Of these five, Etain and Empire State Health Solutions will operate dispensaries in Westchester County. The state plans to implement the program and begin distribution by January 2016.

Hilary Bricken

An Ohio political action group has gone ahead with plans to put a constitutional amendment on the ballot to legalize marijuana amid investigation for fraud. The group was forced to scramble for more signatures after Ohio Secretary of State Jon Husted named a special investigator Wednesday to review what he said were discrepancies in ResponsibleOhio's petitions.